Galway Bay fm newsroom - UHG has completed the final phase of a clinical trial which reduces the hospitalisation rate for patients living with heart failure.
Advertisement
The Cordella sensor is being described as a game-changer as it allows patients be treated for heart failure from home.
An internal audit at UHG of patients who received the sensor noted a 97% decrease in hospitalisation among this group.
Advertisement
Professor Faisal Sharif (pron. Fessel) says the sensor allows patients to send pressure updates to doctors, allowing them to intervene from afar when necessary:
